These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24272202)

  • 1. BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.
    Sheng SH; Zhao CM; Sun GG
    Tumour Biol; 2014 Apr; 35(4):3317-26. PubMed ID: 24272202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis.
    Sun GG; Lu YF; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):2949-57. PubMed ID: 24264312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis.
    Sun GG; Lu YF; Cheng YJ; Yang CR; Liu Q; Jing SW; Han XC
    Tumour Biol; 2014 Dec; 35(12):11771-9. PubMed ID: 25173640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma.
    Sun GG; Wang YD; Cheng YJ; Hu WN
    Tumour Biol; 2014 Oct; 35(10):9707-16. PubMed ID: 24969561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMP1, a member of a new family of antiproliferative genes in breast carcinoma.
    Sun GG; Wang YD; Lu YF; Hu WN
    Tumour Biol; 2014 Apr; 35(4):3347-54. PubMed ID: 24402572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of BTG1 is downregulated in nasopharyngeal carcinoma and possibly associated with tumour metastasis.
    Sun GG; Wang YD; Cheng YJ; Hu WN
    Mol Biol Rep; 2014 Sep; 41(9):5979-88. PubMed ID: 24985971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMP1 inhibits nasopharyngeal cancer cell growth and metastasis through induction apoptosis and angiogenesis.
    Sun GG; Lu YF; Fu ZZ; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):3185-93. PubMed ID: 24292952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BTG1 expression in thyroid carcinoma: diagnostic indicator and prognostic marker.
    Lu YF; Sun GG; Liu Q; Yang CR; Cheng YJ
    Int J Oncol; 2014 Oct; 45(4):1574-82. PubMed ID: 25017022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.
    Sun GG; Sheng SH; Jing SW; Hu WN
    Tumour Biol; 2014 Mar; 35(3):2641-8. PubMed ID: 24241900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMP1 regulates caspase-9 and VEGFC expression and suppresses prostate cancer cell proliferation and invasion.
    Sun GG; Wang YD; Cui DW; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):3455-62. PubMed ID: 24338711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BTG1 expression correlates with the pathogenesis and progression of ovarian carcinomas.
    Zhao Y; Gou WF; Chen S; Takano Y; Xiu YL; Zheng HC
    Int J Mol Sci; 2013 Sep; 14(10):19670-80. PubMed ID: 24084718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absent expression of FLNA is correlated with poor prognosis of nasopharyngeal cancer.
    Sun GG; Lu YF; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):2967-74. PubMed ID: 24218340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between filamin A and MMP-9 regulate proliferation and invasion in renal cell carcinoma.
    Sun GG; Wei CD; Jing SW; Hu WN
    Asian Pac J Cancer Prev; 2014; 15(8):3789-95. PubMed ID: 24870795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B‑cell translocation 1 gene inhibits cellular metastasis‑associated behavior in breast cancer.
    Li W; Zou ST; Zhu R; Wan JM; Xu Y; Wu HR
    Mol Med Rep; 2014 Jun; 9(6):2374-80. PubMed ID: 24714932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Wild-Type p53-Induced Phosphatase 1 Confers Poor Prognosis of Patients with Nasopharyngeal Carcinoma.
    Sun GG; Zhang J; Ma XB; Wang YD; Cheng YJ; Hu WN
    Pathol Oncol Res; 2015 Apr; 21(2):283-91. PubMed ID: 25060857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Wip1 in kidney carcinoma and its correlation with tumor metastasis and clinical significance.
    Sun GG; Wang YD; Liu Q; Hu WN
    Pathol Oncol Res; 2015 Jan; 21(1):219-24. PubMed ID: 24970693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of CCNG2 is significantly linked to the malignant transformation of gastric carcinoma.
    Sun GG; Hu WN; Cui DW; Zhang J
    Tumour Biol; 2014 Mar; 35(3):2631-9. PubMed ID: 24248541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
    Jiang Q; Zhang H; Zhang P
    J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell translocation gene 1 reduces the biological outcome of kidney cancer through induction of cell proliferation, cell cycle arrest, cell apoptosis and cell metastasis.
    Sun G; Liu Q; Cheng Y; Hu W
    Int J Mol Med; 2015 Mar; 35(3):777-83. PubMed ID: 25571854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.